Skip to content

LivaNova LIVN Return on equity

Return on equity at other companies

Abbott logo
AbbottABT
12.4%-18.4pp
Haemonetics logo
HaemoneticsHAE
19.3%+5.2pp
Medtronic logo
MedtronicMDT
9.8%+0.4pp
ResMed logo
ResMedRMD
25.2%-0.6pp
Boston Scientific logo
Boston ScientificBSX
14.8%+5.2pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9.1%0.0pp

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

Based on trailing twelve months.

The official record: LivaNova’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's return on equity?
LivaNova (LIVN) reported return on equity of -17.6% in Q3 2025.
How has LivaNova's return on equity changed year-over-year?
LivaNova's return on equity decreased by 1043.8% year-over-year, from 1.9% to -17.6%.
What is the long-term trend for LivaNova's return on equity?
Over 4 years (2020 to 2024), LivaNova's return on equity has grown at a -35.5% compound annual growth rate (CAGR), from -28% to 4.9%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.